Cevira Chemicals Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-01-2025
- Paid Up Capital ₹ 0.36 M
as on 08-01-2025
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.30 M
as on 08-01-2025
- Revenue %
(FY 2021)
- Profit -53872.26%
(FY 2021)
- Net Worth 109.94%
(FY 2021)
- Total Assets 372.15%
(FY 2021)
About Cevira Chemicals Company
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.36 M.
The company currently has active open charges totaling ₹0.30 M.
Lalitkumar Runwal, Premkala Runwal, and Anjali Shah serve as directors at the Company.
- CIN/LLPIN
U24116PN1985PTC037606
- Company No.
037606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cevira Chemicals Company?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalitkumar Runwal  | Director | 04-Sep-2014 | Current |
| Premkala Runwal | Director | 10-Jan-2008 | Current |
| Anjali Shah | Director | 30-Sep-1985 | Current |
Financial Performance of Cevira Chemicals Company.
Cevira Chemicals Company Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 53872.26% decrease in profit. The company's net worth Soared by an impressive increase of 109.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cevira Chemicals Company?
In 2021, Cevira Chemicals Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ldr Consultancy Services Private LimitedActive 5 years 11 monthsLalitkumar Runwal and Premkala Runwal are mutual person
- Vishwanath Health Care FoundationActive 12 years 6 months
Lalitkumar Runwal, Premkala Runwal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 05 Feb 1988 | ₹0.30 M | Open |
How Many Employees Work at Cevira Chemicals Company?
Unlock and access historical data on people associated with Cevira Chemicals Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cevira Chemicals Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cevira Chemicals Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
